The Beachbody Company, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BODI research report →
Range $9 – $19
Price Chart
About the company
The Beachbody Co. , Inc. operates as a health and wellness company.
- CEO
- Carl Daikeler
- IPO
- 2021
- Employees
- 270
- HQ
- El Segundo, CA, US
Get TickerSpark's AI analysis on BODI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $46.93M
- P/E
- 3.68
- Fwd P/E
- 60.00
- PEG
- 0.00
- P/S
- 0.21
- P/B
- 1.25
- EV/EBITDA
- 1.32
- Div Yield
- 0.00%
- Gross Margin
- 72.89%
- Op Margin
- 8.18%
- Net Margin
- 5.68%
- ROE
- 39.07%
- ROIC
- 26.74%
Latest fiscal year · YoY change
- Revenue
- $251.73M-39.9%
- Gross Profit
- $183.78M-36.0%
- Op Income
- $8.01M
- Net Income
- $-2,860,000+96.0%
- EPS
- $-0.41+96.1%
- OCF Growth
- +748.9%
- FCF Growth
- +976.3%
- 52W High
- $16.87
- 52W Low
- $4.05
- 50D MA
- $9.66
- 200D MA
- $10.16
- Beta
- 1.05
- RSI (14)
- 31
- Avg Volume
- 43.27K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
BODi delivered a profitable quarter with revenue and margins above guidance, while management leaned harder into a nutrition-led multichannel strategy and higher-growth retail/Amazon launches.· August 10, 2026
- Q2 revenue was $49.6 million, with adjusted EBITDA of $6.7 million and net income of $1.4 million, all above guidance.
- This was the company’s fourth straight quarter of positive operating income and net income, and its 11th straight quarter of positive adjusted EBITDA.
- Nutrition is becoming the strategic center of the business, with Shakeology, P90X supplements, Amazon, Sprouts, and Vitamin Shoppe cited as key growth channels.
- Shopify is already changing the economics of the DTC funnel, with management saying it improves conversion, bundle/Subscribe & Save flexibility, and checkout speed.
- The company ended Q2 with $32.4 million in cash and $8.8 million of net cash after amending its credit agreement to a more flexible covenant structure.
Total revenue was $49.6 million in Q2 2026, down 22.4% year over year and down 8.6% sequentially. Digital revenue was $31.2 million, down 21.5% year over year, with digital subscribers at 760,000, down 19.1%; Nutrition and other revenue was $18.5 million, down 23.7% year over year, with nutritional subscriptions at approximately 70,000, essentially flat year over year. Consolidated gross margin was 72%, down 30 basis points year over year; Digital gross margin was 87.1%, and Nutrition and Other gross margin was 46.7%. Operating income was $1.7 million versus an operating loss of $4.0 million a year ago, net income was $1.4 million versus a net loss of $5.9 million a year ago, and adjusted EBITDA was $6.7 million versus $4.6 million a year ago. For Q3 2026, management guided to revenue of $44 million to $48 million, net income of negative $3 million to breakeven, and adjusted EBITDA of $3 million to $6 million; gross margin targets were 86% to 88% for Digital, 42% to 45% for Nutrition and Other, and 68% to 71% consolidated.
Carl Daikeler said Q2 was about executing a shift toward a nutrition-first multichannel model now that the company is freed from the old operating structure’s margin and distribution constraints. He framed Shopify, Amazon, retail expansion, and GLP-1-focused marketing as key tools to improve conversion and broaden the customer funnel, while emphasizing that nutrition products are acquiring customers more efficiently than fitness advertising. His tone was constructive and opportunistic, with repeated comments that the company now has more flexibility to test, learn, and reposition the business for growth.
Brad Ramberg highlighted that revenue, net income, and adjusted EBITDA all beat guidance, with adjusted EBITDA margin at 13.4% and consolidated gross margin at 72%, the high end of the company’s estimated range. He said operating expenses fell 32.1% year over year to $34.1 million, reflecting the removal of MLM seller compensation and other efficiencies, while cash ended at $32.4 million and net cash at $8.8 million. For the first six months of 2026, free cash flow was negative $5.7 million, mainly due to inventory purchases for nutrition and retail rollout plus lower deferred revenue; he also noted the amended credit agreement gives the company more flexibility.
Analysts focused on what is driving nutrition momentum, and management said Q2 growth was largely organic rather than driven by retail, because Sprouts reorders and Vitamin Shoppe launches were only partially reflected in the quarter. Questions on Shopify centered on how quickly website changes can improve conversion ahead of holiday demand; management said the platform is already revealing friction points and enabling faster iteration on landing pages, pricing displays, bundles, and Shop Pay. Analysts also pressed on free cash flow and the new credit covenant, and management responded that cash usage was tied to inventory build and that the amended covenant package provides roughly $7 million more cushion before tests would occur.
The call showed a business that is still shrinking top line, but is now doing so profitably with strong gross margin and positive cash balance. Management sees multiple growth levers ahead: nutrition retail expansion, Amazon launches, Shopify conversion gains, and new fitness programs tied to GLP-1 and strength-training demand. They also pointed to early retail validation from Sprouts and an expanded Vitamin Shoppe rollout as signs that the nutrition strategy is gaining traction.
Revenue declined 22.4% year over year, digital subscribers fell 19.1%, and nutrition revenue also declined, underscoring that the turnaround is not yet producing top-line growth. Free cash flow was negative for the first half, driven by inventory investment and lower deferred revenue, and the company is still navigating planogram timing and retail rollout delays. Management also signaled that 2026 will be a transition year, with more meaningful retail and multichannel benefits expected later, especially in 2027.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 53.0%
- Shares Outstanding
- 7.24M
- Float Shares
- 3.84M
of shares held by institutions
39 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 135.43K | ▼ 1.94K |
Held by 25 ETFs
Biggest fund positions in BODI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 15, 26 | Ramberg Bradley | other | 3,556 |
| Aug 15, 26 | GOLDSTON MARK R | other | 100,000 |
| Jul 15, 26 | Ramberg Bradley | other | 54 |
| Jun 2, 26 | Lundy Ann Marie | other | 9,182 |
| Jun 2, 26 | Van de Bunt Bennet | other | 9,182 |
| Jun 2, 26 | Frank Kristin E. | other | 9,182 |
| Jun 2, 26 | Mayer Kevin A | other | 9,182 |
| Jun 2, 26 | Salter John S. | other | 9,182 |
| Jun 2, 26 | Conlin Mary Murphy | other | 9,182 |
| Jun 2, 26 | Heller Michael | other | 9,182 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BODI coverage
Recent articles, reports, and earnings notes.
No research on BODI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BODI report →Beachbody Details Turnaround, Shakeology Retail Push and P90X Revival at Canaccord Conference
marketbeat.com · Aug 12
The Beachbody Company, Inc. (BODI) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 10
The Beachbody Company, Inc. (BODI) Q2 Earnings Beat Estimates
zacks.com · Aug 10
Beachbody Q2 Earnings Call Highlights
marketbeat.com · Aug 10
Beachbody (BODi) Reports Second Quarter Financial Results
businesswire.com · Aug 10
BODi Announces Second Amendment to Credit Facility
businesswire.com · Aug 6
BODi Expands Retail Presence with Shakeology Now Available at The Vitamin Shoppe Nationwide; Launches New Flavor
businesswire.com · Aug 6
The Beachbody Company, Inc. to Participate in the Canaccord Genuity 46th Annual Growth Conference
businesswire.com · Aug 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.